Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.000
+0.280 (7.53%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Opus Genetics Employees
As of December 31, 2025, Opus Genetics had 28 total employees, including 27 full-time and 1 part-time employees. The number of employees increased by 10 or 55.56% compared to the previous year.
Employees
28
Change (1Y)
10
Growth (1Y)
55.56%
Revenue / Employee
$427,964
Profits / Employee
-$3,819,000
Market Cap
325.58M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Abeona Therapeutics | 226 |
| Rocket Pharmaceuticals | 202 |
| Verastem | 102 |
| Neumora Therapeutics | 92 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 55 |
| Inhibikase Therapeutics | 35 |
IRD News
- 2 days ago - Opus Genetics to join Russell 3000, Russell 2000 and Russell Microcap Indexes - TheFly
- 2 days ago - Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes - GlobeNewsWire
- 5 days ago - Opus Genetics initiated with an Outperform at RBC Capital - TheFly
- 10 days ago - Opus Genetics assumed with a Buy at Chardan - TheFly
- 11 days ago - Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases - GlobeNewsWire
- 12 days ago - Opus Genetics Transcript: R&D Day 2026 - Transcripts
- 12 days ago - Opus Genetics Slides: FY 2026 - Filings
- 15 days ago - Opus Genetics management to meet with BTIG - TheFly